BARBUI, Corrado
 Distribuzione geografica
Continente #
NA - Nord America 19.622
EU - Europa 15.751
AS - Asia 12.282
SA - Sud America 2.027
AF - Africa 233
OC - Oceania 81
Continente sconosciuto - Info sul continente non disponibili 15
Totale 50.011
Nazione #
US - Stati Uniti d'America 19.226
GB - Regno Unito 5.976
SG - Singapore 5.360
CN - Cina 3.792
IT - Italia 1.823
BR - Brasile 1.762
HK - Hong Kong 1.438
RU - Federazione Russa 1.432
FR - Francia 1.422
DE - Germania 1.344
IE - Irlanda 1.082
FI - Finlandia 907
SE - Svezia 883
VN - Vietnam 468
KR - Corea 396
UA - Ucraina 356
CA - Canada 301
TR - Turchia 147
ID - Indonesia 141
NL - Olanda 106
IN - India 101
AT - Austria 89
AR - Argentina 82
AU - Australia 67
ES - Italia 62
BE - Belgio 61
BD - Bangladesh 60
JP - Giappone 57
ZA - Sudafrica 56
TG - Togo 55
MX - Messico 47
EC - Ecuador 42
PL - Polonia 40
IQ - Iraq 36
PE - Perù 34
UZ - Uzbekistan 31
MA - Marocco 29
PK - Pakistan 28
IL - Israele 27
VE - Venezuela 27
MY - Malesia 26
CL - Cile 21
RO - Romania 20
CO - Colombia 19
HU - Ungheria 16
PH - Filippine 16
UY - Uruguay 16
AZ - Azerbaigian 15
KE - Kenya 15
CZ - Repubblica Ceca 14
EU - Europa 14
IR - Iran 14
JO - Giordania 14
SA - Arabia Saudita 14
CH - Svizzera 13
EG - Egitto 13
PY - Paraguay 13
TH - Thailandia 13
AE - Emirati Arabi Uniti 12
GR - Grecia 10
NZ - Nuova Zelanda 10
PT - Portogallo 10
TN - Tunisia 10
BY - Bielorussia 9
BG - Bulgaria 8
BO - Bolivia 8
JM - Giamaica 8
NP - Nepal 8
OM - Oman 8
PA - Panama 8
SK - Slovacchia (Repubblica Slovacca) 8
SN - Senegal 8
DK - Danimarca 7
LT - Lituania 7
DO - Repubblica Dominicana 6
LB - Libano 6
RS - Serbia 6
SI - Slovenia 6
TW - Taiwan 6
EE - Estonia 5
GT - Guatemala 5
LA - Repubblica Popolare Democratica del Laos 5
PS - Palestinian Territory 5
BB - Barbados 4
CD - Congo 4
CG - Congo 4
DZ - Algeria 4
ET - Etiopia 4
HN - Honduras 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LU - Lussemburgo 4
MD - Moldavia 4
NO - Norvegia 4
AL - Albania 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
BS - Bahamas 3
BW - Botswana 3
Totale 49.930
Città #
Southend 5.506
Jacksonville 2.744
Singapore 2.571
Dallas 2.264
Chandler 2.239
Woodbridge 1.651
Hong Kong 1.416
Houston 1.163
Ann Arbor 1.065
Dublin 1.048
Ashburn 779
Beijing 611
Wilmington 529
Lawrence 504
Princeton 501
Verona 497
Nanjing 304
Jinan 296
New York 281
Munich 276
The Dalles 266
Los Angeles 262
Buffalo 247
Shenyang 239
Sindelfingen 212
Milan 190
Helsinki 189
Hebei 176
Redondo Beach 168
São Paulo 141
Montréal 137
Columbus 131
Mcallen 131
Dong Ket 130
Tianjin 126
Boardman 121
Nanchang 113
Changsha 110
Jakarta 109
Santa Clara 109
Haikou 108
Council Bluffs 99
Ho Chi Minh City 98
Ningbo 96
Dearborn 90
Guangzhou 82
Hangzhou 82
Rome 82
Washington 82
Zhengzhou 82
Seattle 77
Jiaxing 75
Lappeenranta 75
San Francisco 73
Norwalk 72
Toronto 72
Redwood City 68
Taizhou 66
Nuremberg 65
Moscow 64
Taiyuan 59
Chicago 57
Lomé 55
Hanoi 53
Lanzhou 53
Rio de Janeiro 52
Brussels 51
Belo Horizonte 49
London 48
Vienna 48
Tokyo 47
Turku 46
Amsterdam 44
Fairfield 42
Kent 42
Redmond 40
Frankfurt am Main 39
Düsseldorf 35
Brasília 33
Brooklyn 33
Fuzhou 33
Bologna 32
Curitiba 32
Montreal 31
Berlin 30
Johannesburg 29
Atlanta 28
Tashkent 27
Porto Alegre 26
Warsaw 26
Stockholm 24
Guayaquil 22
Kuala Lumpur 22
Campinas 21
Istanbul 21
Lancaster 21
Florence 20
Mexico City 20
Boston 19
Dhaka 19
Totale 32.589
Nome #
Forty years without mental hospitals in Italy 609
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 486
WHO Mental Health Gap Action Programme (mhGAP) Intervention Guide: a systematic review of evidence from low and middle-income countries 482
Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis 399
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 345
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 226
Il trattamento farmacologico degli attacchi di panico in medicina generale 201
Psychological treatments versus treatment as usual for obsessive compulsive disorder 194
Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications 186
Come reagiscono al trauma i bambini sfollati? Un’analisi esplorativa degli studi condotti in contesti di guerra. [Displaced versus non-displaced children in war contexts: An explorative analysis of psychological reactions to war experiences] 182
Cerebral atrophy and white matter disruption in chronic schizophrenia 175
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 173
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 160
Assessment of cerebral blood volume in schizophrenia: a magnetic resonance imaging study 158
Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: Systematic review and meta-analysis 158
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 157
What is the WHO essential medicines list? 155
Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies 155
Access to and use of psychiatric services by migrants resettled in Northern Italy 153
Clinical interventions for treatment non-adherence in psychosis: meta-analysis 153
Adverse effects of antipsychotic drugs: survey of doctors' versus patients' perspective. 152
A network meta-analysis of psychosocial interventions for refugees and asylum seekers with PTSD 151
A simple approach to manage dosages in drug-epidemiology research 150
Commentary: Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects 149
Academic psychiatry and the pharmaceutical industry: useful partnership or dangerous interaction? 149
Ricostruzione tridimensionale della volumetria cerebrale nella schizofrenia 148
Predicting costs of mental health care: a critical literature review 148
Assessing risk of bias in randomized controlled trials 147
Efficacia della “Terapia per l’adesione al trattamento” sulla qualità della vita di persone affette da schizofrenia e dei loro familiari (progetto QUATRO). Razionale dello studio e metodologia 145
Antidepressants and benzodiazepines for panic disorder in adults 142
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 141
Cortical white-matter microstructure in schizophrenia. Diffusion imaging study. 141
A New Approach to Psychiatric Drug Approval in Europe 141
Amitriptyline versus other tricyclic drugs and selectivev serotonine reuptake inhibitors (SSRIs) for depression [Protocoll] 139
Access to mental health services and psychotropic drug use in refugees and asylum seekers hosted in high-income countries 138
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 137
Avoidable mortality of psychiatric patients in an area with a community-based system of mental health care. 137
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 136
A practical framework for academics to implement public engagement interventions and measure their impact 132
Guideline implementation strategies for specialist mental healthcare. 131
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare 131
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature 131
What is a systematic review? 130
Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries 130
Rigour of development of clinical practice guidelines for the pharmacological treatment of bipolar disorder: systematic review 130
Are all antidepressants really the same? The case of fluoxetine: a systematic review 129
Antidepressant and antipsychotic drug prescribing in general population in Lombardy (in Italian) 129
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 129
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval 128
Identification and management of depression in primary care settings. A meta-review of evidence 127
Allocation concealment and blinding in clinical trials 127
Associazione tra TCA e SSRI nella depressione resistente 126
"Wish bias" in antidepressant drug trials? 126
Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis 125
Psychological and psychosomatic symptoms of second victims of adverse events: a systematic review and meta-analysis 125
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 124
Dealing with adverse events: a meta-analysis on second victims' coping strategies 124
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 124
Antidepressive Monotherapie 123
Off-label and non-classical prescriptions of antipsychotic agents in ordinary inpatient practice 123
Agomelatine and the brave old world of narrative-based medicine 123
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 123
Violence in psychiatric units. A 7-year Italian study of persistently assaultive patients 122
Citalopram versus other anti-depressive agents for depression 122
Sertraline versus other antidepressive agents for depression 122
Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis 122
A cross-sectional audit of benzodiazepine use among general practice patients. 122
Imputing missing standard deviations in meta-analyses can provide accurate results 121
Randomized trials published in Chinese or Western journals: comparative empirical analysis 121
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 121
First-generation antipsychotics and QTc: any role for mediating variables? 121
Commentary: Antipsychotic plus mood stabiliser co-therapy is more effective than mood stabiliser mono-therapy at reducing acute bipolar mania 120
Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries 120
Efficacy of pharmacotherapy against core traits of borderline personality disorder: Meta-analysis of randomized controlled trials 119
Access to psychotropic medicines in low-resource settings 119
Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine 119
Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence 119
Forty-five years of schizophrenia trials in Italy: a survey 119
What is a forest plot? 118
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 118
La identificación y tratamiento de la enfermedad mental en atención primaria: el caso de la depresión 118
A systematic review of cognitive effects of exercise in depression 117
Medicina basata sulle prove di efficacia e pratica clinica quotidiana: il caso degli antidepressivi 116
Access and use of psychotropic medicines in low-resource settings 116
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 115
Generating psychotropic drug exposure data from computer-based medical records 114
The use of psychotropic drugs in an Italian psychiatric hospital: a two-year-long follow-up study. 114
Antidepressant agents: from tricyclics to serotonin uptake inhibitors. 114
Authors' reply to Magrini and colleagues 114
Association of traumatic events with levels of psychological distress and depressive symptoms in male asylum seekers and refugees resettled in Italy 114
Seven criteria for improving effectiveness trials in psychiatry 113
What is a risk ratio? 113
What is the European Medicines Agency? 113
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 112
Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies 112
Disturbo d'ansia generalizzato: enigma clinico o questione di marketing? 111
Health status, resource consumption, and costs of dysthymic patients in Italian primary care 111
Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data 111
Efficacia della “Terapia per l’adesione al trattamento” sulla qualità della vita di persone affette da schizofrenia e dei loro familiari (progetto QUATRO). Modalità di arruolamento dei soggetti nel centro di Verona e tipo di intervento 111
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders 111
Totale 14.983
Categoria #
all - tutte 193.244
article - articoli 186.060
book - libri 1.006
conference - conferenze 1.196
curatela - curatele 0
other - altro 1.875
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.107
Totale 386.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.802 0 0 0 368 476 463 68 313 288 146 410 270
2021/20223.270 184 725 57 154 249 64 39 221 134 106 340 997
2022/20237.161 602 496 801 1.178 690 1.566 102 479 849 88 189 121
2023/20244.040 209 367 319 448 529 576 205 260 61 180 502 384
2024/202511.203 704 714 557 1.746 589 416 636 585 1.709 831 733 1.983
2025/20266.940 2.289 1.710 2.567 374 0 0 0 0 0 0 0 0
Totale 50.521